{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:52:21Z","timestamp":1793303541879,"version":"4.5.0"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.bioorg.2025.108264","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T10:59:51Z","timestamp":1739012391000},"page":"108264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Insights into curcumin\u2019s anticancer activity in pancreatic ductal adenocarcinoma: Experimental and computational evidence targeting HRAS, CCND1, EGFR and AKT1"],"prefix":"10.1016","volume":"157","author":[{"given":"Jun-Feng","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingjie","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan","family":"Hang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Men","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dunshui","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengliang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kezhou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bioorg.2025.108264_b0005","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/13543784.2019.1557145","article-title":"Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC)","volume":"28","author":"Chandana","year":"2019","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.bioorg.2025.108264_b0010","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/bs.pmbts.2016.09.008","article-title":"Molecular pathogenesis of pancreatic cancer","volume":"144","author":"Grant","year":"2016","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108264_b0015","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41571-023-00746-1","article-title":"Neoadjuvant therapy for pancreatic cancer","volume":"20","author":"Springfeld","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108264_b0020","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1053\/j.gastro.2022.03.056","article-title":"Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment","volume":"163","author":"Wood","year":"2022","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.bioorg.2025.108264_b0025","article-title":"Incidence and risk factors of postoperative complications in general surgery patients","volume":"14","author":"Dharap","year":"2022","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108264_b0030","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/medicina54030048","article-title":"Chemotherapy in pancreatic cancer: a systematic review","volume":"54","author":"Hajatdoost","year":"2018","journal-title":"Medicina (Kaunas)"},{"issue":"Pt 2","key":"10.1016\/j.bioorg.2025.108264_b0035","article-title":"Bioinformatics and experimental approach identify lipocalin 2 as a diagnostic and prognostic indicator for lung adenocarcinoma","volume":"272","author":"Li","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2025.108264_b0040","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/bs.ircmb.2022.11.006","article-title":"Impact of radiation therapy on healthy tissues","volume":"376","author":"Chargari","year":"2023","journal-title":"Int. Rev. Cell Mol. Biol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108264_b0045","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10637-024-01452-0","article-title":"Clinical characteristics, treatment and outcome of pembrolizumab-induced acute pancreatitis","volume":"42","author":"Luo","year":"2024","journal-title":"Invest. New Drugs"},{"issue":"17","key":"10.1016\/j.bioorg.2025.108264_b0050","doi-asserted-by":"crossref","first-page":"13618","DOI":"10.3390\/ijms241713618","article-title":"Targeted therapy for cancers: from ongoing clinical trials to FDA-approved drugs","volume":"24","author":"Choi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108264_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155635","article-title":"Curcumin-primed olfactory mucosa-derived mesenchymal stem cells mitigate cerebral ischemia\/reperfusion injury-induced neuronal PANoptosis by modulating microglial polarization","volume":"129","author":"Lan","year":"2024","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108264_b0060","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/biof.1065","article-title":"Molecular mechanisms of curcumin action: signal transduction","volume":"39","author":"Shehzad","year":"2013","journal-title":"BioFactors (Oxford, England)"},{"issue":"11","key":"10.1016\/j.bioorg.2025.108264_b0065","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s00018-008-7452-4","article-title":"Curcumin: from ancient medicine to current clinical trials","volume":"65","author":"Hatcher","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bioorg.2025.108264_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154090","article-title":"Curcumae rhizoma and its major constituents against hepatobiliary disease: Pharmacotherapeutic properties and potential clinical applications","volume":"102","author":"Gao","year":"2022","journal-title":"Phytomedicine"},{"issue":"11","key":"10.1016\/j.bioorg.2025.108264_b0075","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.3390\/pharmaceutics15112627","article-title":"Curcumin disrupts a positive feedback loop between ADMSCs and cancer cells in the breast tumor microenvironment via the CXCL12\/CXCR4 axis","volume":"15","author":"Jang","year":"2023","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.bioorg.2025.108264_b0080","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/jcmm.17716","article-title":"Influence of cyclin D1 splicing variants expression on breast cancer chemoresistance via CDK4\/CyclinD1-pRB-E2F1 pathway","volume":"27","author":"Wang","year":"2023","journal-title":"J. Cell Mol. Med."},{"issue":"28","key":"10.1016\/j.bioorg.2025.108264_b0085","first-page":"9384","article-title":"Therapeutic applications of curcumin for patients with pancreatic cancer","volume":"20","author":"Kanai","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108264_b0090","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1038\/s41598-020-60765-1","article-title":"Modification of radiosensitivity by Curcumin in human pancreatic cancer cell lines","volume":"10","author":"Schwarz","year":"2020","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108264_b0095","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1002\/ptr.6663","article-title":"Molecular mechanism of curcumin action in signaling pathways: Review of the latest research","volume":"34","author":"Liczbi\u0144ski","year":"2020","journal-title":"Phytotherapy Res.: PTR"},{"issue":"4","key":"10.1016\/j.bioorg.2025.108264_b0100","first-page":"3059","article-title":"The roles of curcumin in regulating the tumor immunosuppressive microenvironment","volume":"19","author":"Wang","year":"2020","journal-title":"Oncol. Lett."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108264_b0105","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1080\/08923973.2018.1469145","article-title":"Curcumin as a therapeutic agent for blocking NF-\u03baB activation in ulcerative colitis","volume":"40","author":"Wang","year":"2018","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108264_b0110","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.freeradbiomed.2007.06.006","article-title":"Curcumin induces apoptosis through mitochondrial hyperpolarization and mtDNA damage in human hepatoma G2 cells","volume":"43","author":"Cao","year":"2007","journal-title":"Free Radic. Biol. Med."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108264_b0115","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.21037\/jgo-22-802","article-title":"Curcumin inhibits pancreatic cancer cell proliferation by regulating Beclin1 expression and inhibiting the hypoxia-inducible factor-1\u03b1-mediated glycolytic pathway","volume":"13","author":"Guo","year":"2022","journal-title":"J. Gastrointestinal Oncol."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108264_b0120","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1007\/s11033-014-3329-9","article-title":"Modulation of apoptosis-related cell signalling pathways by curcumin as a strategy to inhibit tumor progression","volume":"41","author":"Chen","year":"2014","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bioorg.2025.108264_b0125","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3656419","article-title":"Curcumin, a multifaceted hormetic agent, mediates an intricate crosstalk between mitochondrial turnover, autophagy, and apoptosis","volume":"2020","author":"Rainey","year":"2020","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.bioorg.2025.108264_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121076","article-title":"The effect of curcumin on the cadmium-induced mitochondrial apoptosis pathway by metallothionein 2A regulation","volume":"310","author":"Wahyudi","year":"2022","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108264_b0135","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s13277-013-1102-7","article-title":"Curcumin induces osteosarcoma MG63 cells apoptosis via ROS\/Cyto-C\/Caspase-3 pathway","volume":"35","author":"Chang","year":"2014","journal-title":"Tumour Biol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108264_b0140","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0092-8674(00)80434-1","article-title":"Cytochrome c and dATP-dependent formation of Apaf-1\/caspase-9 complex initiates an apoptotic protease cascade","volume":"91","author":"Li","year":"1997","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.bioorg.2025.108264_b0145","doi-asserted-by":"crossref","first-page":"12537","DOI":"10.1002\/jcp.28122","article-title":"Mechanisms of apoptosis modulation by curcumin: Implications for cancer therapy","volume":"234","author":"Mortezaee","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108264_b0150","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3390\/ijms19020448","article-title":"A target for anticancer therapy","volume":"19","author":"Pfeffer","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108264_b0155","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","article-title":"Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108264_b0160","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s13046-019-1320-y","article-title":"Curcumin: a therapeutic strategy in cancers by inhibiting the canonical WNT\/\u03b2-catenin pathway","volume":"38","author":"Vall\u00e9e","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"14","key":"10.1016\/j.bioorg.2025.108264_b0165","first-page":"3107","volume":"44","author":"Liu","year":"2019","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108264_b0170","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/mnfr.201400739","article-title":"Curcumin induces apoptotic cell death via Oct4 inhibition and GSK-3\u03b2 activation in NCCIT cells","volume":"59","author":"Yun","year":"2015","journal-title":"Mol. Nutr. Food Res."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108264_b0175","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.cellsig.2007.10.018","article-title":"GSK-3beta regulates cyclin D1 expression: a new target for chemotherapy","volume":"20","author":"Takahashi-Yanaga","year":"2008","journal-title":"Cell. Signal."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108264_b0180","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2174\/1871530315666150316120458","article-title":"Curcumin targets in inflammation and cancer","volume":"15","author":"Deguchi","year":"2015","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"10.1016\/j.bioorg.2025.108264_b0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113993","article-title":"Disorders of cancer metabolism: The therapeutic potential of cannabinoids","volume":"157","author":"Sun","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108264_b0185","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","article-title":"Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study","volume":"5","author":"Yu","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108264_b0190","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3390\/biom11030392","article-title":"Potential role of curcumin and its nanoformulations to treat various types of cancers","volume":"11","author":"Kabir","year":"2021","journal-title":"Biomolecules"},{"issue":"1\u20134","key":"10.1016\/j.bioorg.2025.108264_b0195","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/biof.5520130125","article-title":"Recent studies on the biofunctions and biotransformations of curcumin","volume":"13","author":"Lin","year":"2000","journal-title":"Biofactors"},{"issue":"5","key":"10.1016\/j.bioorg.2025.108264_b0200","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.3892\/mmr.2016.5037","article-title":"Curcumin induces G2\/M arrest and triggers apoptosis via FoxO1 signaling in U87 human glioma cells","volume":"13","author":"Cheng","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bioorg.2025.108264_b0205","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.901559","article-title":"Effects of GLP-1 receptor agonists on biological behavior of colorectal cancer cells by regulating PI3K\/AKT\/mTOR signaling pathway","volume":"13","author":"Tong","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108264_b0210","doi-asserted-by":"crossref","first-page":"707","DOI":"10.32604\/biocell.2023.026615","article-title":"A comprehensive analysis of the role of molecular docking in the development of anticancer agents against the cell cycle CDK enzyme","volume":"47","author":"Priyanka","year":"2023","journal-title":"Biocell"},{"issue":"7","key":"10.1016\/j.bioorg.2025.108264_b0215","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.3390\/molecules200713384","article-title":"Molecular docking and structure-based drug design strategies","volume":"20","author":"Ferreira","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.108264_b0220","article-title":"Molecular docking in drug discovery: techniques, applications, and advancements","author":"Aguiar","year":"2024","journal-title":"Curr. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108264_b0225","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/med.20067","article-title":"Combining docking and molecular dynamic simulations in drug design","volume":"26","author":"Alonso","year":"2006","journal-title":"Med. Res. Rev."},{"issue":"Suppl 1","key":"10.1016\/j.bioorg.2025.108264_b0230","first-page":"S101","article-title":"Importance of molecular computer modeling in anticancer drug development","volume":"12","author":"Geromichalos","year":"2007","journal-title":"J. BUON"},{"issue":"8","key":"10.1016\/j.bioorg.2025.108264_b0235","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1039\/D2FO03030F","article-title":"Integrated transcriptomics, proteomics and metabolomics to identify biomarkers of astragaloside IV against cerebral ischemic injury in rats","volume":"14","author":"Wei","year":"2023","journal-title":"Food Funct."},{"key":"10.1016\/j.bioorg.2025.108264_b0240","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.1044770","article-title":"Molecular docking and molecular dynamics study Lianhua Qingwen granules (LHQW) treats COVID-19 by inhibiting inflammatory response and regulating cell survival","volume":"12","author":"Cao","year":"2022","journal-title":"Front. Cell Infect. Microbiol."},{"issue":"D1","key":"10.1016\/j.bioorg.2025.108264_b0245","doi-asserted-by":"crossref","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","article-title":"The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets [published correction appears in Nucleic Acids Res. 2021 Oct 11;49(18):10800. doi: 10.1093\/nar\/gkab835","volume":"49","author":"Szklarczyk","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2025.108264_b0250","doi-asserted-by":"crossref","DOI":"10.1177\/20420188231187493","article-title":"Exploring the mechanism of metformin action in Alzheimer's disease and type 2 diabetes based on network pharmacology, molecular docking, and molecular dynamic simulation","volume":"14","author":"Shi","year":"2023","journal-title":"Ther. Adv. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108264_b0255","first-page":"514","article-title":"PANC-1 cancer stem-like cell death with silybin encapsulated in polymersomes and deregulation of stemness-related miRNAs and their potential targets","volume":"24","author":"Khakinezhad Tehrani","year":"2021","journal-title":"Iran. J. Basic Med. Sci."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108264_b0260","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202100389","article-title":"GDP induces PANC-1 human pancreatic cancer cell death preferentially under nutrient starvation by inhibiting PI3K\/Akt\/mTOR\/autophagy signaling pathway","volume":"18","author":"Sun","year":"2021","journal-title":"Chem. Biodivers."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108264_b0265","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5603\/FHC.a2022.0004","article-title":"5-fluorouracil suppresses stem cell-like properties by inhibiting p38 in pancreatic cancer cell line PANC-1","volume":"60","author":"Zhao","year":"2022","journal-title":"Folia Histochem. Cytobiol."},{"key":"10.1016\/j.bioorg.2025.108264_b0270","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.961305","article-title":"The alterations in molecular markers and signaling pathways in chronic thromboembolic pulmonary hypertension, a study with transcriptome sequencing and bioinformatic analysis","volume":"9","author":"Xu","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108264_b0275","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108264_b0280","doi-asserted-by":"crossref","first-page":"7118","DOI":"10.1080\/21655979.2022.2045839","article-title":"Transcriptome sequencing and lncRNA-miRNA-mRNA network construction in cardiac fibrosis and heart failure","volume":"13","author":"Wang","year":"2022","journal-title":"Bioengineered"},{"issue":"Pt 1","key":"10.1016\/j.bioorg.2025.108264_b0285","article-title":"Identifying potential targets for preventing cancer progression through the PLA2G1B recombinant protein using bioinformatics and machine learning methods","volume":"276","author":"Guan","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2025.108264_b0290","article-title":"Clinical features, treatment, and prognosis of SGLT2 inhibitors induced acute pancreatitis","author":"Li","year":"2024","journal-title":"Expert Opin. Drug Saf."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108264_b0295","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13062-020-00267-2","article-title":"AMDock: a versatile graphical tool for assisting molecular docking with Autodock Vina and Autodock4","volume":"15","author":"Vald\u00e9s-Tresanco","year":"2020","journal-title":"Biol. Direct"},{"key":"10.1016\/j.bioorg.2025.108264_b0300","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.965273","article-title":"Exploring the mechanism of action of Xuanfei Baidu granule (XFBD) in the treatment of COVID-19 based on molecular docking and molecular dynamics","volume":"12","author":"Xiong","year":"2022","journal-title":"Front. Cell Infect. Microbiol."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108264_b0305","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108264_b0310","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1080\/07391102.2020.1743757","article-title":"Potential target identification for breast cancer and screening of small molecule inhibitors: A bioinformatics approach","volume":"39","author":"Agarwal","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2025.108264_b0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.106125","article-title":"Computational molecular interaction between SARS-CoV-2 main protease and theaflavin digallate using free energy perturbation and molecular dynamics","volume":"150","author":"Manish","year":"2022","journal-title":"Comput. Biol. Med."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108264_b0320","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1021\/acs.jctc.8b01039","article-title":"Assessment of GAFF2 and OPLS-AA general force fields in combination with the water models TIP3P, SPCE, and OPC3 for the solvation free energy of druglike organic molecules","volume":"15","author":"Vassetti","year":"2019","journal-title":"J. Chem. Theory Comput."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108264_b0325","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","article-title":"ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB","volume":"11","author":"Maier","year":"2015","journal-title":"J. Chem. Theory Comput."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108264_b0330","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10822-019-00267-z","article-title":"Prediction of octanol-water partition coefficients for the SAMPL6-[Formula: see text] molecules using molecular dynamics simulations with OPLS-AA, AMBER and CHARMM force fields","volume":"34","author":"Fan","year":"2020","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"24","key":"10.1016\/j.bioorg.2025.108264_b0335","doi-asserted-by":"crossref","DOI":"10.1063\/1.2943146","article-title":"Implementations of Nos\u00e9-Hoover and Nos\u00e9-Poincar\u00e9 thermostats in mesoscopic dynamic simulations with the united-residue model of a polypeptide chain","volume":"128","author":"Kleinerman","year":"2008","journal-title":"J. Chem. Phys."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108264_b0340","doi-asserted-by":"crossref","DOI":"10.1063\/1.2434972","article-title":"Explicit symplectic integrators of molecular dynamics algorithms for rigid-body molecules in the canonical, isobaric-isothermal, and related ensembles","volume":"126","author":"Okumura","year":"2007","journal-title":"J. Chem. Phys."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108264_b0345","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.1039\/D2CP04238J","article-title":"Structure, energetics and dynamics in crowded amino acid solutions: a molecular dynamics study","volume":"25","author":"Panigrahy","year":"2023","journal-title":"PCCP"},{"issue":"9","key":"10.1016\/j.bioorg.2025.108264_b0350","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a031435","article-title":"KRAS: the critical driver and therapeutic target for pancreatic cancer","volume":"8","author":"Waters","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.bioorg.2025.108264_b0355","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1369136","article-title":"Targeting KRAS mutations in pancreatic cancer: opportunities for future strategies","volume":"11","author":"Linehan","year":"2024","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108264_b0360","doi-asserted-by":"crossref","first-page":"15036","DOI":"10.1038\/s41598-023-41835-6","article-title":"The inhibition of pancreatic cancer progression by K-Ras-overexpressing mesenchymal stem cell-derived secretomes","volume":"13","author":"Huo","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2025.108264_b0365","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.3389\/fonc.2020.01730","article-title":"RPL21siRNA blocks proliferation in pancreatic cancer cells by inhibiting DNA replication and inducing G1 arrest and apoptosis","volume":"10","author":"Li","year":"2020","journal-title":"Front. Oncol."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108264_b0370","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1038\/s41401-020-00584-2","article-title":"Mutations in key driver genes of pancreatic cancer: molecularly targeted therapies and other clinical implications","volume":"42","author":"Hu","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"issue":"8013","key":"10.1016\/j.bioorg.2025.108264_b0375","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s41586-024-07379-z","article-title":"Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer","volume":"629","author":"Wasko","year":"2024","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bioorg.2025.108264_b0380","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201846685","article-title":"HRAS-driven cancer cells are vulnerable to TRPML1 inhibition","volume":"20","author":"Jung","year":"2019","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bioorg.2025.108264_b0385","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-0-387-46401-5_4","article-title":"Modulation of transcription factors by curcumin","volume":"595","author":"Shishodia","year":"2007","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bioorg.2025.108264_b0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111888","article-title":"Pharmacological properties and underlying mechanisms of curcumin and prospects in medicinal potential","volume":"141","author":"Fu","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108264_b0395","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.gendis.2022.05.006","article-title":"Targeting RAS-RAF-MEK-ERK signaling pathway in human cancer: Current status in clinical trials","volume":"10","author":"Song","year":"2022","journal-title":"Genes Diseases"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108264_b0400","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41392-023-01705-z","article-title":"Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: from mechanism to clinical studies","volume":"8","author":"Bahar","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bioorg.2025.108264_b0405","doi-asserted-by":"crossref","first-page":"11581","DOI":"10.1038\/ncomms11581","article-title":"Cytoplasmic cyclin D1 regulates cell invasion and metastasis through the phosphorylation of paxillin","volume":"7","author":"Fust\u00e9","year":"2016","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108264_b0410","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.3390\/ijms21061960","article-title":"The roles of cyclin-dependent kinases in cell-cycle progression and therapeutic strategies in human breast cancer","volume":"21","author":"Ding","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"Suppl 2","key":"10.1016\/j.bioorg.2025.108264_b0415","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s13193-022-01685-6","article-title":"CCND1amplification in pancreatic ductal and ampullary adenocarcinoma and its impact on patients' survival: a single-center observational study","volume":"15","author":"Chakraborty","year":"2024","journal-title":"Indian J. Surg. Oncol."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108264_b0420","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.3390\/cells9122648","article-title":"Cyclin D1 in cancer: a molecular connection for cell cycle control, adhesion and invasion in tumor and stroma","volume":"9","author":"Montalto","year":"2020","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108264_b0425","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s12013-015-0694-5","article-title":"Curcumin promotes cell cycle arrest and inhibits survival of human renal cancer cells by negative modulation of the PI3K\/AKT signaling pathway","volume":"73","author":"Zhang","year":"2015","journal-title":"Cell Biochem. Biophys."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108264_b0430","doi-asserted-by":"crossref","first-page":"716","DOI":"10.14336\/AD.2022.1101","article-title":"Pharmacological mechanisms and clinical applications of curcumin: update","volume":"14","author":"Hao","year":"2023","journal-title":"Aging Dis."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108264_b0435","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.3892\/mmr.2016.4796","article-title":"Curcumin activates autophagy and attenuates oxidative damage in EA.hy926 cells via the Akt\/mTOR pathway","volume":"13","author":"Guo","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bioorg.2025.108264_b0440","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6285099","article-title":"Interference of interleukin-1\u03b2 mediated by lentivirus promotes functional recovery of spinal cord contusion injury in rats via the PI3K\/AKT1 signaling pathway","volume":"2022","author":"Cao","year":"2022","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.bioorg.2025.108264_b0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216332","article-title":"Curcumin in cancer therapy: Exploring molecular mechanisms and overcoming clinical challenges","volume":"570","author":"Wang","year":"2023","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108264_b0450","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.2174\/1389201021666200305115101","article-title":"Curcumin therapeutic modulation of the Wnt signaling pathway","volume":"21","author":"Ashrafizadeh","year":"2020","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108264_b0455","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s13046-019-1320-y","article-title":"Curcumin: a therapeutic strategy in cancers by inhibiting the canonical WNT\/\u03b2-catenin pathway","volume":"38","author":"Vall\u00e9e","year":"2019","journal-title":"J. Exp. Clin. Cancer Res.: CR"},{"key":"10.1016\/j.bioorg.2025.108264_b0460","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejmech.2013.10.073","article-title":"Functionalized curcumin analogs as potent modulators of the Wnt\/\u03b2-catenin signaling pathway","volume":"71","author":"Leow","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108264_b0465","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.intimp.2011.12.009","article-title":"Inhibition of the NF-\u03baB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties","volume":"12","author":"Olivera","year":"2012","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108264_b0470","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.4049\/jimmunol.163.6.3474","article-title":"Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity","volume":"163","author":"Jobin","year":"1999","journal-title":"J. Immunol. (Baltimore, Md.: 1950)"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108264_b0475","first-page":"431","article-title":"Curcumin induces cell cycle arrest and apoptosis of prostate cancer cells by regulating the expression of IkappaBalpha, c-Jun and androgen receptor","volume":"68","author":"Guo","year":"2013","journal-title":"Pharmazie"},{"key":"10.1016\/j.bioorg.2025.108264_b0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120804","article-title":"Curcumin induces mitochondrial apoptosis in human hepatoma cells through BCLAF1-mediated modulation of PI3K\/AKT\/GSK-3\u03b2 signaling","volume":"306","author":"Bai","year":"2022","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108264_b0485","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/humu.20855","article-title":"Oncogenic HRAS mutations cause prolonged PI3K signaling in response to epidermal growth factor in fibroblasts of patients with Costello syndrome","volume":"30","author":"Rosenberger","year":"2009","journal-title":"Hum. Mutat."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108264_b0490","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","article-title":"Targeting PI3K\/Akt signal transduction for cancer therapy","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108264_b0495","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/cancers9050052","article-title":"Epidermal growth factor receptor cell proliferation signaling pathways","volume":"9","author":"Wee","year":"2017","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.bioorg.2025.108264_b0500","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2174\/1568026620666200303123102","article-title":"Review on epidermal growth factor receptor (EGFR) structure, signaling pathways, interactions, and recent updates of EGFR inhibitors","volume":"20","author":"Sabbah","year":"2020","journal-title":"Curr. Top. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108264_b0505","doi-asserted-by":"crossref","first-page":"19868","DOI":"10.1038\/s41598-022-24099-4","article-title":"The diagnostic and prognostic potential of the EGFR\/MUC4\/MMP9 axis in glioma patients","volume":"12","author":"Quesnel","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108264_b0510","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-4827(02)00098-8","article-title":"Epidermal growth factor receptor: mechanisms of activation and signalling","volume":"284","author":"Jorissen","year":"2003","journal-title":"Exp. Cell Res."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108264_b0515","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.3390\/cancers13112748","article-title":"EGFR in cancer: signaling mechanisms, drugs, and acquired resistance","volume":"13","author":"Uribe","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108264_b0520","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/cells10010100","article-title":"Inflammatory cytokines in cancer: comprehensive understanding and clinical progress in gene therapy","volume":"10","author":"Lan","year":"2021","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.bioorg.2025.108264_b0525","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/abbs\/gmy092","article-title":"TGF-\u03b2 signaling in cancer","volume":"50","author":"Gu","year":"2018","journal-title":"Acta Biochim. Biophy. Sin."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108264_b0530","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12943-022-01569-x","article-title":"Targeting TGF-\u03b2 signal transduction for fibrosis and cancer therapy","volume":"21","author":"Peng","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioorg.2025.108264_b0535","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ctrv.2016.12.001","article-title":"Cancer resistance to therapies against the EGFR-RAS-RAF pathway: The role of MEK","volume":"53","author":"Martinelli","year":"2017","journal-title":"Cancer Treat. Rev."},{"issue":"16","key":"10.1016\/j.bioorg.2025.108264_b0540","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.3390\/cancers13163949","article-title":"The pathogenic role of PI3K\/AKT pathway in cancer onset and drug resistance: an updated review","volume":"13","author":"Rascio","year":"2021","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.bioorg.2025.108264_b0545","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1038\/bjc.2014.100","article-title":"Activation of the PI3K\/AKT pathway correlates with prognosis in stage II colon cancer","volume":"110","author":"Malinowsky","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bioorg.2025.108264_b0550","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13046-015-0221-y","article-title":"Metabolic reprogramming: the emerging concept and associated therapeutic strategies","volume":"34","author":"Yoshida","year":"2015","journal-title":"J. Exp. Clin. Cancer Res.: CR"},{"issue":"9","key":"10.1016\/j.bioorg.2025.108264_b0555","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.tcb.2022.02.003","article-title":"Regulation of gene expression by glycolytic and gluconeogenic enzymes","volume":"32","author":"Bian","year":"2022","journal-title":"Trends Cell Biol."},{"issue":"33","key":"10.1016\/j.bioorg.2025.108264_b0560","doi-asserted-by":"crossref","first-page":"34992","DOI":"10.18632\/oncotarget.5252","article-title":"Intracellular activation of EGFR by fatty acid synthase dependent palmitoylation","volume":"6","author":"Bollu","year":"2015","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.bioorg.2025.108264_b0565","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/s41419-021-04262-x","article-title":"Fatty acid synthase (FASN) regulates the mitochondrial priming of cancer cells","volume":"12","author":"Schroeder","year":"2021","journal-title":"Cell Death Dis."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825001440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825001440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T21:31:28Z","timestamp":1763847088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825001440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":114,"alternative-id":["S0045206825001440"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108264","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insights into curcumin\u2019s anticancer activity in pancreatic ductal adenocarcinoma: Experimental and computational evidence targeting HRAS, CCND1, EGFR and AKT1","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108264","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108264"}}